Mayra de Souza El Beck
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mayra de Souza El Beck has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Andréa Trevas Maciel-Guerra
Department of Medical Genetics and Genomic Medicine, School of Medical Sciences, Universidade Estadual de Campinas, Campinas, Brazil
3 shared publications - Antonia Paula Marques-De-Faria
Departamento de Genética Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, Brazil
3 shared publications - Beatriz Amstalden Barros
Interdisciplinary Group for Studies of Sex Determination and Differentiation (GIEDDS), Faculty of Medical Sciences and Clinical Hospital, State University of Campinas (UNICAMP), 13083-887 Campinas, Sao Paulo, Brazil
3 shared publications - Gil Guerra-Júnior
Growth and Development Laboratory (LabCreD), Center for Investigation in Pediatrics, School of Medical Sciences, University of Campinas (Unicamp), Campinas, Brazil
3 shared publications - Helena Fabbri-Scallet
Laboratory of Human Molecular Genetics, Center of Molecular Biology and Genetic Engineering, Universidade Estadual de Campinas, Campinas, Brazil
3 shared publications - Mara Sanches Guaragna
Universidade Estadual de Campinas (UNICAMP), Centro de Biologia Molecular e Engenharia Genética, Laboratório de Genética Humana, Campinas, SP, Brazil
3 shared publications
Latest Publications
- Open Access
- 29 May 2024
- Published by Elsevier in Jornal de Pediatria
- Vol. 100 (6) , 609-613
Patients with genital ambiguity referred without a sex definition: the relationship between clinical picture and defined sex of rearing
- 29 May 2024
- Published by Elsevier in Jornal de Pediatria
- Vol. 100 (6) , 609-613
Open AccessPatients with genital ambiguity referred without a sex definition: the relationship between clinical picture and defined sex of rearing
- Open Access
- 30 July 2022
- Published by Instituto de Saude da Secretaria de Estado da Saude de Sao Paulo in Boletim do Instituto de Saúde - BIS
- Vol. 23 (1) , 113-123
Ambulatório de Gênero e Sexualidades (AmbGen/ HC/ UNICAMP)
0 Ambulatério de Género e Sexualidades (AmbGen) do Hospital das Clinicas da Universidade Estadual de Campinas é um dos poucos dispositivos publicos que acolhem população da infancia e adolescência com variabilidade de género. A psiquiatria e psicologia investigam transtornos mentais, desencadeadores do sofrimento psfquico, disforias relacionados à incongruência de géneto e, no caso de criancas e adolescentes, acolhem as familias buscando compreensao da dinamica familiar, esclarecimento de dúvidas e estigmas. A intervenção hormonal na adolescéncia é possivel em dois momentos: no inicio da puberdade, através de terapia medicamentosa visando blogueio puberal, e hormonização cruzada. A adequação corporal & identidade de género da pessoa trans, através da hormonização, é desejada pela maior parte dos adultos atendidos. A arteterapia realiza atendimentos nos quais busca fornecer padrdes adequados à questdes relevantes, utilizando- se de modalidades expressivas e vivéncias de processos criativos, uma maneira terapéutica diferenciada que propicia um ambiente acolhedor por um viés artistico. Caracteristicas de gênero e voz são muito abrangentes. Sendo assim, a terapia fonoaudiológica a pessoas trans nao se restringe apenas a produção vocal, mas também se relaciona a outros aspectos da comunicagdo e do discurso.
- 30 July 2022
- Published by Instituto de Saude da Secretaria de Estado da Saude de Sao Paulo in Boletim do Instituto de Saúde - BIS
- Vol. 23 (1) , 113-123
Open AccessAmbulatório de Gênero e Sexualidades (AmbGen/ HC/ UNICAMP)
0 Ambulatério de Género e Sexualidades (AmbGen) do Hospital das Clinicas da Universidade Estadual de Campinas é um dos poucos dispositivos publicos que acolhem população da infancia e adolescência com variabilidade de género. A psiquiatria e psicologia investigam transtornos mentais, desencadeadores do sofrimento psfquico, disforias relacionados à incongruência de géneto e, no caso de criancas e adolescentes, acolhem as familias buscando compreensao da dinamica familiar, esclarecimento de dúvidas e estigmas. A intervenção hormonal na adolescéncia é possivel em dois momentos: no inicio da puberdade, através de terapia medicamentosa visando blogueio puberal, e hormonização cruzada. A adequação corporal & identidade de género da pessoa trans, através da hormonização, é desejada pela maior parte dos adultos atendidos. A arteterapia realiza atendimentos nos quais busca fornecer padrdes adequados à questdes relevantes, utilizando- se de modalidades expressivas e vivéncias de processos criativos, uma maneira terapéutica diferenciada que propicia um ambiente acolhedor por um viés artistico. Caracteristicas de gênero e voz são muito abrangentes. Sendo assim, a terapia fonoaudiológica a pessoas trans nao se restringe apenas a produção vocal, mas também se relaciona a outros aspectos da comunicagdo e do discurso.
- Open Access
- 30 April 2022
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 48 (2) , e20210307
Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?
Objective: To determine whether abnormal continuous glucose monitoring (CGM) readings (hypoglycemia/hyperglycemia) can predict the onset of cystic fibrosis-related diabetes (CFRD) and/or clinical impairment (decline in BMI and/or FEV1) in pediatric patients with cystic fibrosis (CF). Methods: This was a longitudinal prospective cohort study involving CF patients without diabetes at baseline. The mean follow-up period was 3.1 years. The patients underwent 3-day CGM, performed oral glucose tolerance test (OGTT), and had FEV1 and BMI determined at baseline. OGTT, FEV1, and BMI were reassessed at the end of the follow-up period. Results: Thirty-nine CF patients (10-19 years of age) had valid CGM readings at baseline, and 34 completed the follow-up period (mean = 3.1 ± 0.5 years). None of the study variables predicted progression to CFRD or were associated with hypoglycemic events. CGM could detect glucose abnormalities not revealed by OGTT. Patients with glucose levels = 140 mg/dL, as compared with those with lower levels, on CGM showed lower BMI values and z-scores at baseline-17.30 ± 3.91 kg/m2 vs. 19.42 ± 2.07 kg/m2; p = 0.043; and -1.55 ± 1.68 vs. -0.17 ± 0.88; p = 0.02, respectively-and at the end of follow-up-17.88 ± 3.63 kg/m2 vs. 19.95 ± 2.56 kg/m2; p = 0.039; and -1.65 ± 1.55 vs. -0.42 ± 1.08; p = 0.039. When comparing patients with and without CFRD, the former were found to have worse FEV1 (in % of predicted)-22.67 ± 5.03 vs. 59.58 ± 28.92; p = 0.041-and a greater decline in FEV1 (-36.00 ± 23.52 vs. -8.13 ± 17.18; p = 0.041) at the end of follow-up. Conclusions: CGM was able to identify glucose abnormalities not detected by OGTT that were related to early-stage decreases in BMI. CGM was ineffective in predicting the onset of diabetes in this CF population. Different diagnostic criteria for diabetes may be required for individuals with CF.
- 30 April 2022
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 48 (2) , e20210307
Open AccessCan continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?
Objective: To determine whether abnormal continuous glucose monitoring (CGM) readings (hypoglycemia/hyperglycemia) can predict the onset of cystic fibrosis-related diabetes (CFRD) and/or clinical impairment (decline in BMI and/or FEV1) in pediatric patients with cystic fibrosis (CF). Methods: This was a longitudinal prospective cohort study involving CF patients without diabetes at baseline. The mean follow-up period was 3.1 years. The patients underwent 3-day CGM, performed oral glucose tolerance test (OGTT), and had FEV1 and BMI determined at baseline. OGTT, FEV1, and BMI were reassessed at the end of the follow-up period. Results: Thirty-nine CF patients (10-19 years of age) had valid CGM readings at baseline, and 34 completed the follow-up period (mean = 3.1 ± 0.5 years). None of the study variables predicted progression to CFRD or were associated with hypoglycemic events. CGM could detect glucose abnormalities not revealed by OGTT. Patients with glucose levels = 140 mg/dL, as compared with those with lower levels, on CGM showed lower BMI values and z-scores at baseline-17.30 ± 3.91 kg/m2 vs. 19.42 ± 2.07 kg/m2; p = 0.043; and -1.55 ± 1.68 vs. -0.17 ± 0.88; p = 0.02, respectively-and at the end of follow-up-17.88 ± 3.63 kg/m2 vs. 19.95 ± 2.56 kg/m2; p = 0.039; and -1.65 ± 1.55 vs. -0.42 ± 1.08; p = 0.039. When comparing patients with and without CFRD, the former were found to have worse FEV1 (in % of predicted)-22.67 ± 5.03 vs. 59.58 ± 28.92; p = 0.041-and a greater decline in FEV1 (-36.00 ± 23.52 vs. -8.13 ± 17.18; p = 0.041) at the end of follow-up. Conclusions: CGM was able to identify glucose abnormalities not detected by OGTT that were related to early-stage decreases in BMI. CGM was ineffective in predicting the onset of diabetes in this CF population. Different diagnostic criteria for diabetes may be required for individuals with CF.
- Open Access
- 1 September 2020
- Published by Elsevier in Jornal de Pediatria (Versão em Português)
- Vol. 96 (5) , 607-613
Why pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service
- 1 September 2020
- Published by Elsevier in Jornal de Pediatria (Versão em Português)
- Vol. 96 (5) , 607-613
Open AccessWhy pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service
- Open Access
- 27 June 2019
- Published by Elsevier in Jornal de Pediatria
- Vol. 96 (5) , 607-613
Why pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service
- 27 June 2019
- Published by Elsevier in Jornal de Pediatria
- Vol. 96 (5) , 607-613
Open AccessWhy pediatricians need to know the disorders of sex development: experience of 709 cases in a specialized service